Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Naturalendo Tech Co. Ltd. (168330:KRX), powered by AI.
Naturalendo Tech Co. Ltd. is currently trading at ₩2,850. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Naturalendo Tech Co. Ltd. on Alpha Lenz.
Naturalendo Tech Co. Ltd.'s P/E ratio is -28.1.
“Naturalendo Tech Co. Ltd. trades at a P/E of -28.1 (undervalued) with modest ROE of -12.6%. 3Y revenue CAGR of 16.8% highlights clear growth momentum.”
Ask for details →Naturalendo Tech Co. Ltd. is a biotechnology company that primarily focuses on the development and commercialization of innovative healthcare solutions. Its primary function is to advance medical research and provide novel treatments and technologies aimed at improving patient outcomes. The company is actively engaged in the fields of drug development, medical devices, and therapeutic procedures, which have significant implications in various sectors, including pharmaceuticals and healthcare services. Founded with a mission to harness the power of biotechnology, Naturalendo Tech Co. Ltd. serves a diverse range of stakeholders, from patients and healthcare providers to research institutions. Its portfolio includes a pipeline of proprietary drugs and state-of-the-art medical instruments, underscoring its commitment to tackling unmet medical needs. Within the financial markets, the company is recognized for its potential to drive innovation and contribute to the evolving landscape of the biomedical industry. By leveraging cutting-edge science and technology, Naturalendo Tech Co. Ltd. plays a pivotal role in providing advanced healthcare solutions that can enhance quality of life globally.
“Naturalendo Tech Co. Ltd. trades at a P/E of -28.1 (undervalued) with modest ROE of -12.6%. 3Y revenue CAGR of 16.8% highlights clear growth momentum.”
Ask for details →Naturalendo Tech Co. Ltd. (ticker: 168330) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 74 employees. Market cap is $90.5B.
The current price is ₩2,850 with a P/E ratio of -28.09x and P/B of 3.77x.
ROE is -12.59% and operating margin is -14.82%. Annual revenue is $22.2B.